Applied Therapeutics, Inc. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 24 rows in 2026. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2026-02-03: Reporting owner Kanter Stacy J.; Form 4; Security Stock Option (Right to Buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2026-02-03: Reporting owner Kanter Stacy J.; Form 4; Security Stock Option (Right to Buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2026-02-03: Reporting owner Kanter Stacy J.; Form 4; Security Stock Option (Right to Buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2026-02-03: Reporting owner Kanter Stacy J.; Form 4; Security Stock Option (Right to Buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-02-03 | Kanter Stacy J. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −20,460 0 owned after | $1.05 exercise price | 2026-02-04 | |
| 2026-02-03 | Kanter Stacy J. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −10,230 0 owned after | $1.05 exercise price | 2026-02-04 | |
| 2026-02-03 | Kanter Stacy J. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −16,500 0 owned after | $1.05 exercise price | 2026-02-04 | |
| 2026-02-03 | Kanter Stacy J. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −16,500 0 owned after | $1.05 exercise price | 2026-02-04 | |
| 2026-02-03 | Kanter Stacy J. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −200,000 0 owned after | $0.40 exercise price | 2026-02-04 | |
| 2026-02-03 | SKYLER JAY S Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −20,460 0 owned after | $1.05 exercise price | 2026-02-03 | |
| 2026-02-03 | SKYLER JAY S Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −10,230 0 owned after | $1.05 exercise price | 2026-02-03 | |
| 2026-02-03 | SKYLER JAY S Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −16,500 0 owned after | $1.05 exercise price | 2026-02-03 | |
| 2026-02-03 | SKYLER JAY S Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −16,500 0 owned after | $1.05 exercise price | 2026-02-03 | |
| 2026-02-03 | SKYLER JAY S Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −200,000 0 owned after | $0.40 exercise price | 2026-02-03 | |
| 2026-02-03 | Funtleyder Leslie D. Director, Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −20,460 0 owned after | $1.05 exercise price | 2026-02-03 | |
| 2026-02-03 | Funtleyder Leslie D. Director, Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −10,230 0 owned after | $1.05 exercise price | 2026-02-03 | |
| 2026-02-03 | Funtleyder Leslie D. Director, Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −16,500 0 owned after | $1.05 exercise price | 2026-02-03 | |
| 2026-02-03 | Funtleyder Leslie D. Director, Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −16,500 0 owned after | $1.05 exercise price | 2026-02-03 | |
| 2026-02-03 | Funtleyder Leslie D. Director, Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −150,000 0 owned after | $1.02 exercise price | 2026-02-03 | |
| 2026-02-03 | Funtleyder Leslie D. Director, Officer (Chief Financial Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −40,502 0 owned after | $4.70 exercise price | 2026-02-03 | |
| 2026-02-03 | Bailey Evan Prescott Officer (Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −19,531 0 owned after | $1.05 exercise price | 2026-02-03 | |
| 2026-02-03 | Bailey Evan Prescott Officer (Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −4,883 0 owned after | $1.05 exercise price | 2026-02-03 | |
| 2026-02-03 | Lerner Teena Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −20,460 0 owned after | $1.05 exercise price | 2026-02-03 | |
| 2026-02-03 | Lerner Teena Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −10,230 0 owned after | $1.05 exercise price | 2026-02-03 | |
| 2026-02-03 | Lerner Teena Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −16,500 0 owned after | $1.05 exercise price | 2026-02-03 | |
| 2026-02-03 | Lerner Teena Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −16,500 0 owned after | $1.05 exercise price | 2026-02-03 | |
| 2026-02-03 | Lerner Teena Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −200,000 0 owned after | $0.40 exercise price | 2026-02-03 | |
| 2026-02-03 | Lerner Teena Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −23,941 0 owned after | $4.70 exercise price | 2026-02-03 |